BioNTech initiates global trials of mRNA-based lung cancer vaccine
The trial will be conducted across seven countries and will involve approximately 130 patients.
Trilink Thematic mRNA WP
Everest Medicines launches personalised mRNA cancer vaccine trial
Pfizer and BioNTech’s Covid-19/flu combination vaccine falters in Phase III readout
WestGene’s cancer vaccine gets approvals in the US and China to advance trials
Altamira’s drug-delivering nanoparticles could treat AAA
Rznomics to commence RNA editing therapy trial for retinitis pigmentosa
Sirnaomics completes IND-enabling trials of siRNA therapy STP125G
Sirnaomics concludes second cohort of Phase I RNAi therapeutic trial
